Costedoat-Chalumeau, Nathalie <br/><br/>
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.  [electronic resource] 

 -  Arthritis and rheumatism  Nov 2003 
 - 3207-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.11304  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--pharmacokinetics<br/>Birth Weight--drug effects<br/>Child<br/>Child, Preschool<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hydroxychloroquine--pharmacokinetics<br/>Infant<br/>Infant, Newborn<br/>Lupus Erythematosus, Systemic--complications<br/>Maternal Age<br/>Maternal Exposure<br/>Maternal-Fetal Exchange<br/>Pregnancy<br/>Pregnancy Complications<br/>Pregnancy Outcome<br/>Pregnancy, High-Risk<br/>Prenatal Exposure Delayed Effects